Table 1.
Demographics and clinical features of 413 patients with Parkinson’s disease
| Variables | Patients (n = 413) |
|---|---|
| Age, years | 65.2 ± 9.0 |
| Men, n (%) | 227 (55.0) |
| HY stage* | 2.2 ± 0.7 |
| UPDRS II† | 8.6 ± 5.8 |
| UPDRS III‡ | 19.8 ± 10.7 |
| Motor fluctuation, n (%) | 108 (26.2) |
| Dyskinesia, n (%) | 143 (34.6) |
| ESS | 8.4 ± 5.4 |
| GDS-30§ | 11.9 ± 7.3 |
| Lateralityǁ, n (%) | |
| Right | 153 (37.5) |
| Left | 127 (31.1) |
| Symmetric | 128 (31.4) |
| Total LEDD | 829.5 ± 388.2 |
| Levodopa | 488.1 ± 261.3 |
| Ropinirole¶ | 8.4 ± 5.5 |
*
data missing from two patients,
†
data missing from seven patients,
‡
data missing from one patient,
§
data missing from six patients,
ǁ
data missing from five patients,
¶
the mean value of ropinirole is presented as LEDD.
HY stage: Hoehn and Yahr stage, UPDRS: Unified Parkinson’s Disease Rating Scale, ESS: Epworth Sleepiness Scale, GDS-30: 30-item Geriatric Depression Scale, LEDD: levodopa equivalent daily dose.